Literature DB >> 19020857

Hyperglycaemia and reduced risk of prostate cancer.

R P F Dullaart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020857     DOI: 10.1007/s00125-008-1214-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  8 in total

1.  A meta-analysis of diabetes mellitus and the risk of prostate cancer.

Authors:  Jocelyn S Kasper; Edward Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

2.  Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.

Authors:  Julius Gudmundsson; Patrick Sulem; Valgerdur Steinthorsdottir; Jon T Bergthorsson; Gudmar Thorleifsson; Andrei Manolescu; Thorunn Rafnar; Daniel Gudbjartsson; Bjarni A Agnarsson; Adam Baker; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Margret Jakobsdottir; Thorarinn Blondal; Simon N Stacey; Agnar Helgason; Steinunn Gunnarsdottir; Adalheidur Olafsdottir; Kari T Kristinsson; Birgitta Birgisdottir; Shyamali Ghosh; Steinunn Thorlacius; Dana Magnusdottir; Gerdur Stefansdottir; Kristleifur Kristjansson; Yu Bagger; Robert L Wilensky; Muredach P Reilly; Andrew D Morris; Charlotte H Kimber; Adebowale Adeyemo; Yuanxiu Chen; Jie Zhou; Wing-Yee So; Peter C Y Tong; Maggie C Y Ng; Torben Hansen; Gitte Andersen; Knut Borch-Johnsen; Torben Jorgensen; Alejandro Tres; Fernando Fuertes; Manuel Ruiz-Echarri; Laura Asin; Berta Saez; Erica van Boven; Siem Klaver; Dorine W Swinkels; Katja K Aben; Theresa Graif; John Cashy; Brian K Suarez; Onco van Vierssen Trip; Michael L Frigge; Carole Ober; Marten H Hofker; Cisca Wijmenga; Claus Christiansen; Daniel J Rader; Colin N A Palmer; Charles Rotimi; Juliana C N Chan; Oluf Pedersen; Gunnar Sigurdsson; Rafn Benediktsson; Eirikur Jonsson; Gudmundur V Einarsson; Jose I Mayordomo; William J Catalona; Lambertus A Kiemeney; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-07-01       Impact factor: 38.330

Review 3.  Finasteride.

Authors:  R S Rittmaster
Journal:  N Engl J Med       Date:  1994-01-13       Impact factor: 91.245

4.  5alpha-reductase: history and clinical importance.

Authors:  Leonard S Marks
Journal:  Rev Urol       Date:  2004

Review 5.  Hyperglycemic pseudohypoxia and diabetic complications.

Authors:  J R Williamson; K Chang; M Frangos; K S Hasan; Y Ido; T Kawamura; J R Nyengaard; M van den Enden; C Kilo; R G Tilton
Journal:  Diabetes       Date:  1993-06       Impact factor: 9.461

6.  Alterations in cortisol metabolism in insulin-dependent diabetes mellitus: relationship with metabolic control and estimated blood volume and effect of angiotensin-converting enzyme inhibition.

Authors:  R P Dullaart; F L Ubels; K Hoogenberg; A J Smit; J J Pratt; J H Muntinga; W J Sluiter; B G Wolthers
Journal:  J Clin Endocrinol Metab       Date:  1995-10       Impact factor: 5.958

7.  A genetic link between type 2 diabetes and prostate cancer.

Authors:  T M Frayling; H Colhoun; J C Florez
Journal:  Diabetologia       Date:  2008-08-12       Impact factor: 10.122

Review 8.  Prostate cancer prevention: past, present, and future.

Authors:  Neil Fleshner; Alexandre R Zlotta
Journal:  Cancer       Date:  2007-11-01       Impact factor: 6.860

  8 in total
  1 in total

1.  Hyperglycemia, Classified with Multiple Biomarkers Simultaneously in Men without Diabetes, and Risk of Fatal Prostate Cancer.

Authors:  Michael T Marrone; Elizabeth Selvin; John R Barber; Elizabeth A Platz; Corinne E Joshu
Journal:  Cancer Prev Res (Phila)       Date:  2018-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.